We are live on
!
Find out more
RI
Ridgewood Investments Portfolio holdings
AUM
$244M
This Fund
S&P 500
This Quarter
Est. Return
-14.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$25.4M
(-17%)
Cap. Flow
-$2.61M
Cap. Flow
% of AUM
-2.06%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
206
New
12
Increased
61
Reduced
68
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$968K |
| 2 |
Core Laboratories
CLB
|
+$636K |
| 3 |
Citigroup
C
|
+$530K |
| 4 |
Coinbase
COIN
|
+$520K |
| 5 |
Qualcomm
QCOM
|
+$498K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PetMed Express
PETS
|
+$1.15M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$573K |
| 3 |
Royalty Pharma
RPRX
|
+$527K |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$495K |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$470K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.03% |
| 2 | Healthcare | 13.3% |
| 3 | Technology | 8.58% |
| 4 | Consumer Discretionary | 7.86% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.06T
| $14.5M | 11.38% |
52,975
-72
| -0.1% | -$22.6K |
|
2
Vanguard S&P 500 ETF
VOO
$974B
| $2.86M | 2.25% |
8,248
-706
| -8% | -$266K |
|
3
Vanguard Total World Stock ETF
VT
$76.6B
| $2.74M | 2.15% |
32,078
-2,684
| -8% | -$248K |
|
4
Markel Group
MKL
$24.7B
| $2.73M | 2.15% |
2,115
+29
| +1% | +$39.8K |
|
5
Invesco S&P 500 Low Volatility ETF
SPLV
$7.19B
| $2.04M | 1.61% |
32,952
-292
| -0.9% | -$18.9K |
|
6
Henry Schein
HSIC
$10B
| $2.03M | 1.6% |
26,500
| – | – |
|
7
3M
MMM
$83.4B
| $1.83M | 1.44% |
16,953
+942
| +6% | +$114K |
|
8
Alphabet (Google) Class A
GOOGL
$4.23T
| $1.75M | 1.38% |
16,080
+680
| +4% | +$80.1K |
|
9
Vanguard Russell 1000 Value ETF
VONV
$20.4B
| $1.7M | 1.34% |
26,739
-3,010
| -10% | -$207K |
|
10
Vanguard Small-Cap ETF
VB
$79.7B
| $1.66M | 1.31% |
9,442
-793
| -8% | -$153K |
|
|
11
Alphabet (Google) Class C
GOOG
$4.22T
| $1.62M | 1.27% |
14,800
+680
| +5% | +$80.3K |
|
12
Vanguard Mid-Cap ETF
VO
$106B
| $1.61M | 1.27% |
32,656
-4,176
| -11% | -$226K |
|
13
Prudential Financial
PRU
$41.4B
| $1.47M | 1.16% |
15,353
-1
| -0% | -$106 |
|
14
Gilead Sciences
GILD
$167B
| $1.43M | 1.12% |
23,101
-1
| -0% | -$62 |
|
|
15
Qualcomm
QCOM
$181B
| $1.32M | 1.04% |
10,362
+3,667
| +55% | +$498K |
|
16
Intel
INTC
$478B
| $1.28M | 1.01% |
34,202
+6,819
| +25% | +$295K |
|
17
Verizon
VZ
$182B
| $1.26M | 0.99% |
24,822
+647
| +3% | +$32.7K |
|
18
RCI Hospitality Holdings
RICK
$200M
| $1.21M | 0.95% |
24,958
| – | – |
|
19
Kimberly-Clark
KMB
$36B
| $1.2M | 0.95% |
8,910
-1
| -0% | -$132 |
|
20
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
| $1.2M | 0.94% |
17,046
+7
| +0% | +$512 |
|
21
Cardinal Health
CAH
$53.5B
| $1.15M | 0.9% |
21,948
-450
| -2% | -$25.6K |
|
|
HBI
22
DELISTED
Hanesbrands
HBI
| $1.14M | 0.9% |
110,910
+10,134
| +10% | +$126K |
|
23
MSC Industrial Direct
MSM
$6.97B
| $1.14M | 0.9% |
15,182
-1
| -0% | -$82 |
|
|
24
Citigroup
C
$217B
| $1.12M | 0.88% |
24,360
+10,588
| +77% | +$530K |
|
25
Goldman Sachs
GS
$314B
| $1.1M | 0.87% |
3,702
+293
| +9% | +$91.2K |
|
Similar funds
JP
LAM
LHCM
LC
IAMOG
CA
BNMT
BB
Ridgewood Investments's Q2 2022 Portfolio in Review
As of Q2 2022, Ridgewood Investments held 206 positions worth $127M, down 17% from $152M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ridgewood Investments's Q2 2022 filing shows 12 new, 61 increased, 68 reduced and 20 closed positions. Its largest new stake was Organon & Co: 27,648 shares worth $933K. The largest sale was PetMed Express, an estimated $1.15M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Ridgewood Investments's largest Q2 2022 buy was Organon & Co: 27,648 shares worth $933K.
- Ridgewood Investments added most to Citigroup in Q2 2022, an estimated $530K increase.
- Ridgewood Investments's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $527K.
- Ridgewood Investments fully exited PetMed Express in Q2 2022, selling an estimated $1.15M.
- Ridgewood Investments's ten largest holdings make up 27% of its $127M portfolio in Q2 2022.
- Ridgewood Investments opened 12 new positions and closed 20 in Q2 2022.
- Ridgewood Investments's portfolio value fell 17% quarter-over-quarter to $127M.
Based on Ridgewood Investments's 13F filing for Q2 2022, filed 19 Jul 2022.